Three GLP-1 injections have been FDA-approved for weight loss, including : FDA-approved oral weight loss medications include: Qsymia ( phentermine /topiramate) Contrave (naltrexone/bupropion) Xenical (orlistat) All of these require a prescription from a licensed healthcare provider
Projected settlement range examples from comparable GLP-1 litigation: $50,000 to $100,000 for cases with relatively limited documented harm $100,000 to $300,000 for significant medical treatment and extended care $300,000 to $500,000 for serious, enduring injuries with substantial costs $500,000 to $700,000+ for severe or permanently disabling conditions These projections are estimates, not guarantees, and actual outcomes for Victoza injury claims will vary based on individual case details
The guide to how peptides work covers these receptor dynamics in broader context, explaining how the body interacts with exogenous peptides across different therapeutic applications
The mechanism of action is attributed to the GIP/GLP-1 receptor co-agonism being enhanced by glucagon receptor activation and augmentation of energy intake, substrate utilisation and energy expenditure [60]